(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
(Zip code) | |||
(Address of principal executive offices) |
Securities registered pursuant to Section 12(b) of the Act: | ||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Emerging growth company | |
☐ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act |
Exhibit No. | Description |
99.1 | Press Release, dated February 27, 2020 (furnished pursuant to Item 2.02). |
104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document) |
EXLSERVICE HOLDINGS, INC. (Registrant) | ||
Date: February 27, 2020 | By: | /s/ Ajay Ayyappan |
Name: | Ajay Ayyappan | |
Title: | General Counsel and Corporate Secretary |
99.1 |
• | Revenues for the quarter ended December 31, 2019 increased to $256.9 million compared to $234.9 million for the fourth quarter of 2018, an increase of 9.4% on a reported basis and 9.3% on a constant currency basis from the fourth quarter of 2018, as well as an increase of 2.2% sequentially on a reported basis and 2.0% on a constant currency basis, from the third quarter of 2019. |
Revenues | Gross Margin | ||||||||||||||||||||
Three months ended | Three months ended | ||||||||||||||||||||
Dec 31, | Dec 31, | Sept 30, | Dec 31, | Dec 31, | Sept 30, | ||||||||||||||||
Reportable Segments | 2019 | 2018 | 2019 | 2019 | 2018 | 2019 | |||||||||||||||
(dollars in millions) | |||||||||||||||||||||
Insurance | $ | 75.2 | $ | 65.1 | $ | 77.7 | 31.4 | % | 31.0 | % | 33.7 | % | |||||||||
Healthcare | 26.0 | 21.4 | 24.0 | 21.6 | % | 20.5 | % | 19.1 | % | ||||||||||||
Travel, Transportation & Logistics | 16.1 | 16.9 | 17.0 | 43.2 | % | 40.6 | % | 42.2 | % | ||||||||||||
Finance & Accounting | 27.9 | 25.2 | 26.5 | 41.2 | % | 40.7 | % | 37.3 | % | ||||||||||||
All Other | 18.0 | 20.4 | 17.4 | 35.1 | % | 32.5 | % | 29.1 | % | ||||||||||||
Analytics | 93.7 | 85.9 | 88.8 | 37.0 | % | 36.8 | % | 34.8 | % | ||||||||||||
Total revenues, net | $ | 256.9 | $ | 234.9 | $ | 251.4 | 34.5 | % | 34.0 | % | 33.4 | % |
• | Operating income margin for the quarter ended December 31, 2019 was 9.1%, compared to an operating loss margin of 0.9% for the fourth quarter of 2018 and operating income margin of 8.9% for the third quarter of 2019. During the quarters ended December 31, 2019 and 2018 and September 30, 2019, we recorded impairment and restructuring charges of $1.4 million, $20.1 million and $0.5 million, respectively, related to the wind down of the Health Integrated business, which reduced our operating income margin by approximately 50 basis points, 850 basis points and 20 basis points, respectively. The wind down of the Health Integrated business was substantially completed on December 31, 2019 and we do not expect to incur impairment and restructuring charges in 2020. Adjusted operating income margin for the quarter ended December 31, 2019 was 13.3% compared to 13.1% for the fourth quarter of 2018 and 14.3% for the third quarter of 2019. |
• | Diluted earnings per share for the quarter ended December 31, 2019 was $0.62 compared to $0.11 for the fourth quarter of 2018 and $0.55 for the third quarter of 2019. During the quarters ended December 31, 2019 and 2018 and September 30, 2019, we recorded impairment and restructuring charges of $1.4 million ($1.0 million net of tax), $20.1 million ($17.0 million net of tax) and $0.5 million ($0.4 million net of tax), respectively, related to the wind down of the Health Integrated business, which reduced our diluted earnings per share by $0.03, $0.49 and $0.01, respectively. Adjusted diluted earnings per share for the quarter ended December 31, 2019 was $0.79 compared to $0.74 for the fourth quarter of 2018 and $0.84 for the third quarter of 2019. |
• | Revenues for the year ended December 31, 2019 increased to $991.3 million compared to $883.1 million for the year ended December 31, 2018, an increase of 12.3% on a reported basis and 13.0% on a constant currency basis. |
Revenues | Gross Margin | |||||||||||||
Year ended | Year ended | |||||||||||||
Reportable Segments | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2018 | ||||||||||
(dollars in millions) | ||||||||||||||
Insurance | $ | 294.2 | $ | 258.1 | 32.1 | % | 32.2 | % | ||||||
Healthcare | 90.6 | 84.4 | 18.7 | % | 20.9 | % | ||||||||
Travel, Transportation & Logistics | 68.0 | 70.2 | 43.0 | % | 41.5 | % | ||||||||
Finance & Accounting | 106.6 | 97.9 | 40.6 | % | 39.6 | % | ||||||||
All Other | 74.6 | 87.2 | 34.6 | % | 33.0 | % | ||||||||
Analytics | 357.3 | 285.3 | 35.3 | % | 35.3 | % | ||||||||
Total revenues, net | $ | 991.3 | $ | 883.1 | 33.9 | % | 33.8 | % |
• | Operating income margin for the year ended December 31, 2019 was 7.7% compared to 5.6% for the year ended December 31, 2018. During the year 2019 and 2018, we recorded impairment and restructuring charges of $8.7 million and $20.1 million, respectively, related to the wind down of the Health Integrated business, which reduced our operating income margin by approximately 90 basis points and 230 basis points, respectively. The wind down of the Health Integrated business was substantially completed on December 31, 2019 and we do not expect to incur impairment and restructuring charges in 2020. Adjusted operating income margin for the year ended December 31, 2019 was 13.4% compared to 13.5% for the year ended December 31, 2018. |
• | Diluted earnings per share for the year ended December 31, 2019 was $1.95 compared to $1.62 for the year ended December 31, 2018. During the year 2019 and 2018, we recorded impairment and restructuring charges of $8.7 million ($6.5 million net of tax) and $20.1 million ($17.0 million net of tax), respectively, related to the wind down of the Health Integrated business, which reduced our diluted earnings per share by $0.19 and $0.49 for the year ended December 31, 2019 and 2018, respectively. Adjusted diluted earnings per share for the year ended December 31, 2019 was $3.09 compared to $2.77 for the year ended December 31, 2018. |
• | Won five new clients in the fourth quarter of 2019, including two in our operations management businesses and three in Analytics. For the full year, we won 28 new clients, 14 in operations management and 14 in Analytics |
• | Recognized as a Leader in the IDC MarketScape: Worldwide Analytics for Business Operations Services 2019 Vendor Assessment |
• | Positioned as a Leader in the Everest Group Advanced Analytics & Insights Services PEAK Matrix™ Assessment 2020 |
• | Recognized as a Leader in the ISG Provider Lens for Insurance BPO Digital Services - U.S. 2019 for Property & Casualty Insurance Services, Life & Annuity Digital Services and Life & Annuity TPA Services |
• | Appointed Maurizio Nicolelli to the role of Executive Vice President, Chief Financial Officer and member of the Executive Committee |
• | Appointed Vivek Jetley to the role of Executive Vice President, Head of Analytics and member of the Executive Committee |
• | Revenue of $1.040 billion to $1.065 billion, representing an annual revenue growth rate of 5% to 8% on a constant currency basis. |
• | Adjusted diluted earnings per share of $3.42 to $3.58. |
(Unaudited) | |||||||||||||||
Year ended December 31, | Three months ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenues, net | $ | 991,346 | $ | 883,112 | $ | 256,872 | $ | 234,903 | |||||||
Cost of revenues(1) | 655,490 | 584,855 | 168,262 | 154,948 | |||||||||||
Gross profit(1) | 335,856 | 298,257 | 88,610 | 79,955 | |||||||||||
Operating expenses: | |||||||||||||||
General and administrative expenses | 126,909 | 116,202 | 33,560 | 30,592 | |||||||||||
Selling and marketing expenses | 71,842 | 63,612 | 17,846 | 18,019 | |||||||||||
Depreciation and amortization expense | 51,981 | 48,566 | 12,515 | 13,381 | |||||||||||
Impairment and restructuring charges | 8,671 | 20,056 | 1,375 | 20,056 | |||||||||||
Total operating expenses | 259,403 | 248,436 | 65,296 | 82,048 | |||||||||||
Income/(loss) from operations | 76,453 | 49,821 | 23,314 | (2,093 | ) | ||||||||||
Foreign exchange gain, net | 3,752 | 4,787 | 281 | 1,373 | |||||||||||
Interest expense | (13,612 | ) | (7,227 | ) | (2,986 | ) | (3,508 | ) | |||||||
Other income, net | 16,507 | 12,989 | 3,419 | 4,757 | |||||||||||
Income before income tax expense and earnings from equity affiliates | 83,100 | 60,370 | 24,028 | 529 | |||||||||||
Income tax expense/(benefit) | 15,172 | 3,397 | 2,601 | (3,399 | ) | ||||||||||
Income before earnings from equity affiliates | 67,928 | 56,973 | 21,427 | 3,928 | |||||||||||
Loss from equity-method investment | 269 | 247 | 71 | 71 | |||||||||||
Net income attributable to ExlService Holdings, Inc. stockholders | $ | 67,659 | $ | 56,726 | $ | 21,356 | $ | 3,857 | |||||||
Earnings per share attributable to ExlService Holdings, Inc. stockholders: | |||||||||||||||
Basic | $ | 1.97 | $ | 1.65 | $ | 0.62 | $ | 0.11 | |||||||
Diluted | $ | 1.95 | $ | 1.62 | $ | 0.62 | $ | 0.11 | |||||||
Weighted-average number of shares used in computing earnings per share attributable to ExlService Holdings Inc. stockholders: | |||||||||||||||
Basic | 34,350,150 | 34,451,008 | 34,253,308 | 34,388,025 | |||||||||||
Diluted | 34,732,683 | 35,030,984 | 34,696,896 | 34,921,388 |
As of | |||||||
December 31, 2019 | December 31, 2018 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 119,165 | $ | 95,881 | |||
Short-term investments | 202,238 | 184,489 | |||||
Restricted cash | 5,453 | 5,608 | |||||
Accounts receivable, net | 171,864 | 164,752 | |||||
Prepaid expenses | 13,246 | 11,326 | |||||
Advance income tax, net | 4,698 | 9,639 | |||||
Other current assets | 24,594 | 28,240 | |||||
Total current assets | 541,258 | 499,935 | |||||
Property and equipment, net | 79,142 | 73,510 | |||||
Operating lease right-of-use assets | 86,396 | — | |||||
Restricted cash | 2,426 | 2,642 | |||||
Deferred tax assets, net | 11,855 | 6,602 | |||||
Intangible assets, net | 73,982 | 95,495 | |||||
Goodwill | 349,529 | 349,984 | |||||
Other assets | 36,016 | 31,015 | |||||
Investment in equity affiliate | 2,484 | 2,753 | |||||
Total assets | $ | 1,183,088 | $ | 1,061,936 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 6,564 | $ | 5,653 | |||
Current portion of long-term borrowings | 40,867 | 21,423 | |||||
Deferred revenue | 13,436 | 7,722 | |||||
Accrued employee costs | 71,626 | 54,893 | |||||
Accrued expenses and other current liabilities | 71,023 | 64,169 | |||||
Current portion of operating lease liabilities | 24,148 | — | |||||
Income taxes payable, net | 1,432 | 1,012 | |||||
Current portion of finance lease liabilities | 253 | 223 | |||||
Total current liabilities | 229,349 | 155,095 | |||||
Long-term borrowings, less current portion | 194,131 | 263,241 | |||||
Finance lease liabilities, less current portion | 430 | 315 | |||||
Income taxes payable | 1,790 | — | |||||
Deferred tax liabilities, net | 966 | 8,445 | |||||
Operating lease liabilities, less current portion | 74,709 | — | |||||
Other non-current liabilities | 11,712 | 16,521 | |||||
Total liabilities | 513,087 | 443,617 | |||||
Commitments and contingencies | |||||||
Preferred stock, $0.001 par value; 15,000,000 shares authorized, none issued | — | — | |||||
ExlService Holdings, Inc. Stockholders’ equity: | |||||||
Common stock, $0.001 par value; 100,000,000 shares authorized, 38,480,654 shares issued and 34,185,241 shares outstanding as of December 31, 2019 and 37,850,544 shares issued and 34,222,476 shares outstanding as of December 31, 2018 | 39 | 38 | |||||
Additional paid-in capital | 391,240 | 364,179 | |||||
Retained earnings | 551,903 | 484,244 | |||||
Accumulated other comprehensive loss | (84,892 | ) | (83,467 | ) | |||
Total including shares held in treasury | 858,290 | 764,994 | |||||
Less: 4,295,413 shares as of December 31, 2019 and 3,628,068 shares as of December 31, 2018, held in treasury, at cost | (188,289 | ) | (146,925 | ) | |||
Stockholders' equity | $ | 670,001 | $ | 618,069 | |||
Non-controlling interest | — | 250 | |||||
Total equity | $ | 670,001 | $ | 618,319 | |||
Total liabilities and stockholders’ equity | $ | 1,183,088 | $ | 1,061,936 |
Year ended | Three months ended | |||||||||||||||||||
December 31, | December 31, | September 30, | ||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | ||||||||||||||||
Net income (GAAP) | $ | 67,659 | $ | 56,726 | $ | 21,356 | $ | 3,857 | $ | 19,044 | ||||||||||
add: Income tax expense/(benefit) | 15,172 | 3,397 | 2,601 | (3,399 | ) | 5,701 | ||||||||||||||
subtract: Interest expense, foreign exchange gain, net, loss from equity-method investment and other income, net | (6,378 | ) | (10,302 | ) | (643 | ) | (2,551 | ) | (2,323 | ) | ||||||||||
Income/(loss) from operations (GAAP) | $ | 76,453 | $ | 49,821 | $ | 23,314 | $ | (2,093 | ) | $ | 22,422 | |||||||||
add: Stock-based compensation expense | 26,070 | 23,901 | 4,532 | 6,590 | 7,427 | |||||||||||||||
add: Amortization of acquisition-related intangibles | 21,558 | 20,377 | 4,974 | 5,951 | 5,502 | |||||||||||||||
add: Impairment and restructuring charges (a) | 8,671 | 20,056 | 1,375 | 20,056 | 489 | |||||||||||||||
add: Provision for litigation settlement (b) | — | 2,400 | — | — | — | |||||||||||||||
add: Acquisition-related expenses (c) | — | 2,295 | — | 236 | — | |||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 132,752 | $ | 118,850 | $ | 34,195 | $ | 30,740 | $ | 35,840 | ||||||||||
Adjusted operating income margin as a % of Revenues (Non-GAAP) | 13.4 | % | 13.5 | % | 13.3 | % | 13.1 | % | 14.3 | % | ||||||||||
add: Depreciation | 30,423 | 28,189 | 7,541 | 7,430 | 7,545 | |||||||||||||||
Adjusted EBITDA (Non-GAAP) | $ | 163,175 | $ | 147,039 | $ | 41,736 | $ | 38,170 | $ | 43,385 | ||||||||||
Adjusted EBITDA margin as a % of revenue (Non-GAAP) | 16.5 | % | 16.7 | % | 16.2 | % | 16.2 | % | 17.3 | % | ||||||||||
(a) To exclude impairment and restructuring charges related to wind down of the Health Integrated business. (b) To exclude provision for litigation settlement recorded during the three months ended March 31, 2018. (c) To exclude acquisition-related expenses. |
Year ended | Three months ended | |||||||||||||||||||
December 31, | December 31, | September 30, | ||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | ||||||||||||||||
Net income (GAAP) | $ | 67,659 | $ | 56,726 | $ | 21,356 | $ | 3,857 | $ | 19,044 | ||||||||||
add: Stock-based compensation expense | 26,070 | 23,901 | 4,532 | 6,590 | 7,427 | |||||||||||||||
add: Amortization of acquisition-related intangibles | 21,558 | 20,377 | 4,974 | 5,951 | 5,502 | |||||||||||||||
add: Impairment and restructuring charges (a) | 8,671 | 20,056 | 1,375 | 20,056 | 489 | |||||||||||||||
add: Provision for litigation settlement (b) | — | 2,400 | — | — | — | |||||||||||||||
add: Acquisition-related (benefits)/expenses (c) | (761 | ) | 1,045 | — | (1,014 | ) | (761 | ) | ||||||||||||
add: Non-cash interest expense related to convertible senior notes (d) | 2,472 | 600 | 636 | 600 | 618 | |||||||||||||||
subtract: Effect of Tax Reform Act and other non-recurring tax expenses/(benefits) (e) | (3,134 | ) | (7,810 | ) | (1,663 | ) | (2,974 | ) | — | |||||||||||
subtract: Tax impact on stock-based compensation expense (f) | (7,986 | ) | (12,101 | ) | (2,144 | ) | (2,837 | ) | (1,790 | ) | ||||||||||
subtract: Tax impact on amortization of acquisition-related intangibles | (4,621 | ) | (4,351 | ) | (1,042 | ) | (1,511 | ) | (1,188 | ) | ||||||||||
subtract: Tax impact on impairment and restructuring charges | (2,140 | ) | (3,072 | ) | (352 | ) | (3,072 | ) | (120 | ) | ||||||||||
subtract: Tax impact on provision for litigation settlement | — | (612 | ) | — | — | — | ||||||||||||||
subtract: Tax impact on acquisition-related expenses/(benefits) | 186 | (15 | ) | — | 253 | 186 | ||||||||||||||
subtract: Tax impact on non-cash interest expense related to convertible senior notes | (606 | ) | (150 | ) | (159 | ) | (150 | ) | (150 | ) | ||||||||||
Adjusted net income (Non-GAAP) | $ | 107,368 | $ | 96,994 | $ | 27,513 | $ | 25,749 | $ | 29,257 | ||||||||||
Adjusted diluted earnings per share (Non-GAAP) | $ | 3.09 | $ | 2.77 | $ | 0.79 | $ | 0.74 | $ | 0.84 |